Results 151 to 160 of about 1,971,842 (244)
IgG4‐Related Disease Presenting as Inflammatory Midline Pseudotumor of the Face and Neck
ABSTRACT A 78‐year‐old Chinese woman presented with a one‐year history of a progressively enlarging purpuric rash over the central face and nasal dorsum, with subsequent development of a firm midline neck mass. Histopathology revealed dense lymphoplasmacytic infiltrate with fibrosis and obliterative phlebitis.
Rowena Lee Ying Kwan +4 more
wiley +1 more source
Doxofylline: Another drug causing fixed drug eruption
Subramanian Kumudhini +3 more
doaj +1 more source
Maculopapular-Type Drug Eruption Caused by Cetuximab. [PDF]
Ikegawa N, Saito-Sasaki N, Sawada Y.
europepmc +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Anna Malfertheiner +2 more
wiley +1 more source
ABSTRACT We report a patient with chronic myeloid leukemia who developed giant cellulitis‐like Sweet syndrome with concurrent retiform petechiae and vasculitis‐like histopathological changes. This case highlights a potential diagnostic pitfall whereby Sweet syndrome may clinically and histologically mimic cutaneous vasculitis.
Kangjie R. Chua +2 more
wiley +1 more source
Semaglutide-induced fixed drug eruption
Sahithi Talasila, BS +5 more
doaj +1 more source
Preferential Localization of Fixed Drug Eruption Over a Cosmetic Red Lip Tattoo. [PDF]
Radhi Y, Almamoori A.
europepmc +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Irene Rivera‐Ruiz +5 more
wiley +1 more source
ABSTRACT This article examines the British government's response to the August 2011 English riots through the lens of state crime, drawing on Richards and Avery's ‘Thug State’ concept. It addresses the relative neglect of the state's response itself as a potential form of criminality and social harm.
Monia O'Brien Castro
wiley +1 more source
ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra +5 more
wiley +1 more source

